nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—P-Glycoprotein Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.411	0.623	CiPCiCtD
Zonisamide—P-Glycoprotein Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.249	0.377	CiPCiCtD
Zonisamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0148	0.0923	CbGbCtD
Zonisamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0139	0.0868	CbGbCtD
Zonisamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0126	0.0785	CbGbCtD
Zonisamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0126	0.0785	CbGbCtD
Zonisamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0109	0.0678	CbGbCtD
Zonisamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0106	0.0658	CbGbCtD
Zonisamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00954	0.0595	CbGbCtD
Zonisamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00954	0.0595	CbGbCtD
Zonisamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00915	0.0571	CbGbCtD
Zonisamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00716	0.0446	CbGbCtD
Zonisamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00673	0.042	CbGbCtD
Zonisamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00673	0.042	CbGbCtD
Zonisamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00609	0.038	CbGbCtD
Zonisamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00609	0.038	CbGbCtD
Zonisamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00525	0.0328	CbGbCtD
Zonisamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0051	0.0318	CbGbCtD
Zonisamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00461	0.0288	CbGbCtD
Zonisamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00461	0.0288	CbGbCtD
Zonisamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00442	0.0276	CbGbCtD
Zonisamide—CA13—nerve—acquired immunodeficiency syndrome	0.00211	0.038	CbGeAlD
Zonisamide—CA6—saliva—acquired immunodeficiency syndrome	0.00198	0.0357	CbGeAlD
Zonisamide—SCN11A—nerve—acquired immunodeficiency syndrome	0.00144	0.026	CbGeAlD
Zonisamide—SCN2B—spinal cord—acquired immunodeficiency syndrome	0.000774	0.0139	CbGeAlD
Zonisamide—CA11—retina—acquired immunodeficiency syndrome	0.000733	0.0132	CbGeAlD
Zonisamide—CA10—spinal cord—acquired immunodeficiency syndrome	0.000671	0.0121	CbGeAlD
Zonisamide—SCN2B—nervous system—acquired immunodeficiency syndrome	0.000652	0.0117	CbGeAlD
Zonisamide—SCN3B—spinal cord—acquired immunodeficiency syndrome	0.000646	0.0116	CbGeAlD
Zonisamide—SCN1B—lung—acquired immunodeficiency syndrome	0.000637	0.0115	CbGeAlD
Zonisamide—SCN2B—central nervous system—acquired immunodeficiency syndrome	0.000628	0.0113	CbGeAlD
Zonisamide—SCN3B—vagina—acquired immunodeficiency syndrome	0.000621	0.0112	CbGeAlD
Zonisamide—CA13—digestive system—acquired immunodeficiency syndrome	0.000613	0.0111	CbGeAlD
Zonisamide—CA1—nerve—acquired immunodeficiency syndrome	0.000606	0.0109	CbGeAlD
Zonisamide—SCN1B—nervous system—acquired immunodeficiency syndrome	0.00059	0.0106	CbGeAlD
Zonisamide—SCN3B—lung—acquired immunodeficiency syndrome	0.000588	0.0106	CbGeAlD
Zonisamide—SCN1B—central nervous system—acquired immunodeficiency syndrome	0.000568	0.0102	CbGeAlD
Zonisamide—CA10—nervous system—acquired immunodeficiency syndrome	0.000565	0.0102	CbGeAlD
Zonisamide—CA8—nervous system—acquired immunodeficiency syndrome	0.000554	0.00999	CbGeAlD
Zonisamide—SCN4B—spinal cord—acquired immunodeficiency syndrome	0.000549	0.00989	CbGeAlD
Zonisamide—CA10—central nervous system—acquired immunodeficiency syndrome	0.000544	0.00981	CbGeAlD
Zonisamide—SCN3B—nervous system—acquired immunodeficiency syndrome	0.000544	0.00981	CbGeAlD
Zonisamide—CA13—vagina—acquired immunodeficiency syndrome	0.000542	0.00976	CbGeAlD
Zonisamide—CA8—central nervous system—acquired immunodeficiency syndrome	0.000534	0.00962	CbGeAlD
Zonisamide—SCN4B—vagina—acquired immunodeficiency syndrome	0.000528	0.00952	CbGeAlD
Zonisamide—SCN3B—central nervous system—acquired immunodeficiency syndrome	0.000524	0.00944	CbGeAlD
Zonisamide—CA13—lung—acquired immunodeficiency syndrome	0.000512	0.00923	CbGeAlD
Zonisamide—SCN4B—lung—acquired immunodeficiency syndrome	0.0005	0.009	CbGeAlD
Zonisamide—SCN2B—brain—acquired immunodeficiency syndrome	0.000498	0.00898	CbGeAlD
Zonisamide—MAOB—nerve—acquired immunodeficiency syndrome	0.000492	0.00887	CbGeAlD
Zonisamide—CA11—blood—acquired immunodeficiency syndrome	0.000491	0.00884	CbGeAlD
Zonisamide—CA11—bone marrow—acquired immunodeficiency syndrome	0.000475	0.00855	CbGeAlD
Zonisamide—CA13—nervous system—acquired immunodeficiency syndrome	0.000474	0.00855	CbGeAlD
Zonisamide—CA4—nerve—acquired immunodeficiency syndrome	0.000474	0.00854	CbGeAlD
Zonisamide—CA11—spinal cord—acquired immunodeficiency syndrome	0.000473	0.00852	CbGeAlD
Zonisamide—SCN4B—nervous system—acquired immunodeficiency syndrome	0.000463	0.00834	CbGeAlD
Zonisamide—CA1—blood plasma—acquired immunodeficiency syndrome	0.000458	0.00826	CbGeAlD
Zonisamide—CA13—central nervous system—acquired immunodeficiency syndrome	0.000457	0.00823	CbGeAlD
Zonisamide—CA11—vagina—acquired immunodeficiency syndrome	0.000455	0.0082	CbGeAlD
Zonisamide—SCN1B—brain—acquired immunodeficiency syndrome	0.000451	0.00812	CbGeAlD
Zonisamide—SCN4B—central nervous system—acquired immunodeficiency syndrome	0.000445	0.00803	CbGeAlD
Zonisamide—SCN1B—lymph node—acquired immunodeficiency syndrome	0.000435	0.00785	CbGeAlD
Zonisamide—CA10—brain—acquired immunodeficiency syndrome	0.000432	0.00779	CbGeAlD
Zonisamide—CA11—lung—acquired immunodeficiency syndrome	0.00043	0.00775	CbGeAlD
Zonisamide—CA8—brain—acquired immunodeficiency syndrome	0.000424	0.00764	CbGeAlD
Zonisamide—SCN11A—digestive system—acquired immunodeficiency syndrome	0.00042	0.00757	CbGeAlD
Zonisamide—MAOA—nerve—acquired immunodeficiency syndrome	0.00042	0.00756	CbGeAlD
Zonisamide—SCN3B—brain—acquired immunodeficiency syndrome	0.000416	0.00749	CbGeAlD
Zonisamide—CA8—lymph node—acquired immunodeficiency syndrome	0.000409	0.00738	CbGeAlD
Zonisamide—SCN3B—lymph node—acquired immunodeficiency syndrome	0.000402	0.00724	CbGeAlD
Zonisamide—CACNA1G—digestive system—acquired immunodeficiency syndrome	0.0004	0.00722	CbGeAlD
Zonisamide—CA11—nervous system—acquired immunodeficiency syndrome	0.000398	0.00718	CbGeAlD
Zonisamide—SCN11A—spinal cord—acquired immunodeficiency syndrome	0.000385	0.00694	CbGeAlD
Zonisamide—CA11—central nervous system—acquired immunodeficiency syndrome	0.000383	0.00691	CbGeAlD
Zonisamide—MAOB—blood plasma—acquired immunodeficiency syndrome	0.000372	0.0067	CbGeAlD
Zonisamide—CA13—brain—acquired immunodeficiency syndrome	0.000363	0.00653	CbGeAlD
Zonisamide—SCN4B—brain—acquired immunodeficiency syndrome	0.000354	0.00637	CbGeAlD
Zonisamide—CA13—lymph node—acquired immunodeficiency syndrome	0.00035	0.00631	CbGeAlD
Zonisamide—CACNA1I—brain—acquired immunodeficiency syndrome	0.000345	0.00622	CbGeAlD
Zonisamide—CA7—digestive system—acquired immunodeficiency syndrome	0.000343	0.00617	CbGeAlD
Zonisamide—SCN4B—lymph node—acquired immunodeficiency syndrome	0.000342	0.00616	CbGeAlD
Zonisamide—CACNA1I—lymph node—acquired immunodeficiency syndrome	0.000334	0.00601	CbGeAlD
Zonisamide—SCN11A—nervous system—acquired immunodeficiency syndrome	0.000325	0.00585	CbGeAlD
Zonisamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000324	0.00584	CbGeAlD
Zonisamide—MAOA—blood plasma—acquired immunodeficiency syndrome	0.000317	0.00572	CbGeAlD
Zonisamide—SCN11A—central nervous system—acquired immunodeficiency syndrome	0.000313	0.00563	CbGeAlD
Zonisamide—CACNA1G—nervous system—acquired immunodeficiency syndrome	0.00031	0.00558	CbGeAlD
Zonisamide—CA11—brain—acquired immunodeficiency syndrome	0.000304	0.00549	CbGeAlD
Zonisamide—CA9—digestive system—acquired immunodeficiency syndrome	0.000301	0.00542	CbGeAlD
Zonisamide—CACNA1G—central nervous system—acquired immunodeficiency syndrome	0.000298	0.00537	CbGeAlD
Zonisamide—CA2—blood plasma—acquired immunodeficiency syndrome	0.000297	0.00535	CbGeAlD
Zonisamide—CA11—lymph node—acquired immunodeficiency syndrome	0.000294	0.0053	CbGeAlD
Zonisamide—CA3—bone marrow—acquired immunodeficiency syndrome	0.00029	0.00522	CbGeAlD
Zonisamide—CA3—vagina—acquired immunodeficiency syndrome	0.000277	0.005	CbGeAlD
Zonisamide—CA3—lung—acquired immunodeficiency syndrome	0.000262	0.00473	CbGeAlD
Zonisamide—CA14—spinal cord—acquired immunodeficiency syndrome	0.000262	0.00472	CbGeAlD
Zonisamide—SCN9A—spinal cord—acquired immunodeficiency syndrome	0.000257	0.00462	CbGeAlD
Zonisamide—SCN11A—brain—acquired immunodeficiency syndrome	0.000248	0.00447	CbGeAlD
Zonisamide—CA3—nervous system—acquired immunodeficiency syndrome	0.000243	0.00438	CbGeAlD
Zonisamide—CACNA1G—brain—acquired immunodeficiency syndrome	0.000237	0.00427	CbGeAlD
Zonisamide—CA3—central nervous system—acquired immunodeficiency syndrome	0.000234	0.00422	CbGeAlD
Zonisamide—SCN9A—lung—acquired immunodeficiency syndrome	0.000233	0.00421	CbGeAlD
Zonisamide—CA12—digestive system—acquired immunodeficiency syndrome	0.000223	0.00401	CbGeAlD
Zonisamide—SCN1A—spinal cord—acquired immunodeficiency syndrome	0.000221	0.00398	CbGeAlD
Zonisamide—SCN2A—blood—acquired immunodeficiency syndrome	0.00021	0.00379	CbGeAlD
Zonisamide—CACNA1H—nervous system—acquired immunodeficiency syndrome	0.000203	0.00365	CbGeAlD
Zonisamide—SCN2A—spinal cord—acquired immunodeficiency syndrome	0.000203	0.00365	CbGeAlD
Zonisamide—CA7—brain—acquired immunodeficiency syndrome	0.000202	0.00365	CbGeAlD
Zonisamide—SCN1A—lung—acquired immunodeficiency syndrome	0.000201	0.00362	CbGeAlD
Zonisamide—SCN2A—vagina—acquired immunodeficiency syndrome	0.000195	0.00351	CbGeAlD
Zonisamide—SCN5A—digestive system—acquired immunodeficiency syndrome	0.000193	0.00349	CbGeAlD
Zonisamide—SCN4A—nervous system—acquired immunodeficiency syndrome	0.000193	0.00348	CbGeAlD
Zonisamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000192	0.00345	CbGeAlD
Zonisamide—CA5B—blood—acquired immunodeficiency syndrome	0.00019	0.00343	CbGeAlD
Zonisamide—SCN1A—nervous system—acquired immunodeficiency syndrome	0.000186	0.00335	CbGeAlD
Zonisamide—CA12—lung—acquired immunodeficiency syndrome	0.000186	0.00335	CbGeAlD
Zonisamide—CA3—brain—acquired immunodeficiency syndrome	0.000186	0.00335	CbGeAlD
Zonisamide—SCN4A—central nervous system—acquired immunodeficiency syndrome	0.000186	0.00335	CbGeAlD
Zonisamide—AOX1—digestive system—acquired immunodeficiency syndrome	0.000186	0.00335	CbGeAlD
Zonisamide—SCN3A—blood—acquired immunodeficiency syndrome	0.000185	0.00333	CbGeAlD
Zonisamide—SCN5A—blood—acquired immunodeficiency syndrome	0.000184	0.00332	CbGeAlD
Zonisamide—CA3—lymph node—acquired immunodeficiency syndrome	0.000179	0.00323	CbGeAlD
Zonisamide—SCN1A—central nervous system—acquired immunodeficiency syndrome	0.000179	0.00323	CbGeAlD
Zonisamide—SCN3A—bone marrow—acquired immunodeficiency syndrome	0.000179	0.00322	CbGeAlD
Zonisamide—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.000178	0.00322	CbGeAlD
Zonisamide—SCN3A—spinal cord—acquired immunodeficiency syndrome	0.000178	0.00321	CbGeAlD
Zonisamide—CA1—digestive system—acquired immunodeficiency syndrome	0.000176	0.00318	CbGeAlD
Zonisamide—CA5B—vagina—acquired immunodeficiency syndrome	0.000176	0.00318	CbGeAlD
Zonisamide—MAOA—retina—acquired immunodeficiency syndrome	0.000174	0.00313	CbGeAlD
Zonisamide—CA12—nervous system—acquired immunodeficiency syndrome	0.000172	0.0031	CbGeAlD
Zonisamide—SCN3A—vagina—acquired immunodeficiency syndrome	0.000171	0.00309	CbGeAlD
Zonisamide—SCN5A—vagina—acquired immunodeficiency syndrome	0.000171	0.00308	CbGeAlD
Zonisamide—SCN2A—nervous system—acquired immunodeficiency syndrome	0.000171	0.00308	CbGeAlD
Zonisamide—CA14—brain—acquired immunodeficiency syndrome	0.000169	0.00304	CbGeAlD
Zonisamide—CA1—blood—acquired immunodeficiency syndrome	0.000168	0.00303	CbGeAlD
Zonisamide—CA5B—lung—acquired immunodeficiency syndrome	0.000167	0.003	CbGeAlD
Zonisamide—CA12—central nervous system—acquired immunodeficiency syndrome	0.000166	0.00299	CbGeAlD
Zonisamide—SCN9A—brain—acquired immunodeficiency syndrome	0.000165	0.00298	CbGeAlD
Zonisamide—SCN2A—central nervous system—acquired immunodeficiency syndrome	0.000164	0.00296	CbGeAlD
Zonisamide—AOX1—vagina—acquired immunodeficiency syndrome	0.000164	0.00295	CbGeAlD
Zonisamide—CA2—retina—acquired immunodeficiency syndrome	0.000163	0.00293	CbGeAlD
Zonisamide—CA1—bone marrow—acquired immunodeficiency syndrome	0.000162	0.00293	CbGeAlD
Zonisamide—SCN3A—lung—acquired immunodeficiency syndrome	0.000162	0.00292	CbGeAlD
Zonisamide—CA1—spinal cord—acquired immunodeficiency syndrome	0.000162	0.00292	CbGeAlD
Zonisamide—SCN9A—lymph node—acquired immunodeficiency syndrome	0.00016	0.00288	CbGeAlD
Zonisamide—AOX1—lung—acquired immunodeficiency syndrome	0.000155	0.00279	CbGeAlD
Zonisamide—CACNA1H—brain—acquired immunodeficiency syndrome	0.000155	0.00279	CbGeAlD
Zonisamide—CA5B—nervous system—acquired immunodeficiency syndrome	0.000154	0.00278	CbGeAlD
Zonisamide—SCN3A—nervous system—acquired immunodeficiency syndrome	0.00015	0.0027	CbGeAlD
Zonisamide—CACNA1H—lymph node—acquired immunodeficiency syndrome	0.00015	0.0027	CbGeAlD
Zonisamide—SCN5A—nervous system—acquired immunodeficiency syndrome	0.00015	0.0027	CbGeAlD
Zonisamide—CA5B—central nervous system—acquired immunodeficiency syndrome	0.000149	0.00268	CbGeAlD
Zonisamide—SCN4A—brain—acquired immunodeficiency syndrome	0.000147	0.00266	CbGeAlD
Zonisamide—CA1—lung—acquired immunodeficiency syndrome	0.000147	0.00265	CbGeAlD
Zonisamide—SCN3A—central nervous system—acquired immunodeficiency syndrome	0.000144	0.0026	CbGeAlD
Zonisamide—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000144	0.0026	CbGeAlD
Zonisamide—MAOB—digestive system—acquired immunodeficiency syndrome	0.000143	0.00258	CbGeAlD
Zonisamide—CA2—skin of body—acquired immunodeficiency syndrome	0.000143	0.00257	CbGeAlD
Zonisamide—SCN1A—brain—acquired immunodeficiency syndrome	0.000142	0.00256	CbGeAlD
Zonisamide—CA4—digestive system—acquired immunodeficiency syndrome	0.000138	0.00248	CbGeAlD
Zonisamide—CA1—nervous system—acquired immunodeficiency syndrome	0.000136	0.00246	CbGeAlD
Zonisamide—MAOB—blood—acquired immunodeficiency syndrome	0.000136	0.00246	CbGeAlD
Zonisamide—CA12—brain—acquired immunodeficiency syndrome	0.000132	0.00237	CbGeAlD
Zonisamide—MAOB—spinal cord—acquired immunodeficiency syndrome	0.000131	0.00237	CbGeAlD
Zonisamide—CA4—blood—acquired immunodeficiency syndrome	0.000131	0.00237	CbGeAlD
Zonisamide—CA1—central nervous system—acquired immunodeficiency syndrome	0.000131	0.00237	CbGeAlD
Zonisamide—SCN2A—brain—acquired immunodeficiency syndrome	0.00013	0.00235	CbGeAlD
Zonisamide—CA4—bone marrow—acquired immunodeficiency syndrome	0.000127	0.00229	CbGeAlD
Zonisamide—CA4—spinal cord—acquired immunodeficiency syndrome	0.000126	0.00228	CbGeAlD
Zonisamide—MAOB—vagina—acquired immunodeficiency syndrome	0.000126	0.00228	CbGeAlD
Zonisamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000125	0.00225	CbGeAlD
Zonisamide—MAOA—digestive system—acquired immunodeficiency syndrome	0.000122	0.0022	CbGeAlD
Zonisamide—MAOB—lung—acquired immunodeficiency syndrome	0.000119	0.00215	CbGeAlD
Zonisamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000119	0.00214	CbGeAlD
Zonisamide—CA5B—brain—acquired immunodeficiency syndrome	0.000118	0.00213	CbGeAlD
Zonisamide—MAOA—blood—acquired immunodeficiency syndrome	0.000116	0.0021	CbGeAlD
Zonisamide—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.000116	0.00208	CbGeAlD
Zonisamide—CA4—lung—acquired immunodeficiency syndrome	0.000115	0.00207	CbGeAlD
Zonisamide—SCN3A—brain—acquired immunodeficiency syndrome	0.000115	0.00207	CbGeAlD
Zonisamide—SCN5A—brain—acquired immunodeficiency syndrome	0.000114	0.00206	CbGeAlD
Zonisamide—CA2—digestive system—acquired immunodeficiency syndrome	0.000114	0.00206	CbGeAlD
Zonisamide—CA5B—lymph node—acquired immunodeficiency syndrome	0.000114	0.00205	CbGeAlD
Zonisamide—MAOA—spinal cord—acquired immunodeficiency syndrome	0.000112	0.00202	CbGeAlD
Zonisamide—SCN3A—lymph node—acquired immunodeficiency syndrome	0.000111	0.002	CbGeAlD
Zonisamide—MAOB—nervous system—acquired immunodeficiency syndrome	0.000111	0.00199	CbGeAlD
Zonisamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.00011	0.00198	CbGeAlD
Zonisamide—AOX1—brain—acquired immunodeficiency syndrome	0.00011	0.00198	CbGeAlD
Zonisamide—CA2—blood—acquired immunodeficiency syndrome	0.000109	0.00196	CbGeAlD
Zonisamide—MAOA—vagina—acquired immunodeficiency syndrome	0.000108	0.00194	CbGeAlD
Zonisamide—CA4—nervous system—acquired immunodeficiency syndrome	0.000107	0.00192	CbGeAlD
Zonisamide—MAOB—central nervous system—acquired immunodeficiency syndrome	0.000107	0.00192	CbGeAlD
Zonisamide—AOX1—lymph node—acquired immunodeficiency syndrome	0.000106	0.00191	CbGeAlD
Zonisamide—CA2—bone marrow—acquired immunodeficiency syndrome	0.000105	0.0019	CbGeAlD
Zonisamide—CA2—spinal cord—acquired immunodeficiency syndrome	0.000105	0.00189	CbGeAlD
Zonisamide—CA1—brain—acquired immunodeficiency syndrome	0.000104	0.00188	CbGeAlD
Zonisamide—CA4—central nervous system—acquired immunodeficiency syndrome	0.000103	0.00185	CbGeAlD
Zonisamide—MAOA—lung—acquired immunodeficiency syndrome	0.000102	0.00184	CbGeAlD
Zonisamide—CA2—vagina—acquired immunodeficiency syndrome	0.000101	0.00182	CbGeAlD
Zonisamide—CA1—lymph node—acquired immunodeficiency syndrome	0.000101	0.00181	CbGeAlD
Zonisamide—CA2—lung—acquired immunodeficiency syndrome	9.54e-05	0.00172	CbGeAlD
Zonisamide—MAOA—nervous system—acquired immunodeficiency syndrome	9.44e-05	0.0017	CbGeAlD
Zonisamide—MAOA—central nervous system—acquired immunodeficiency syndrome	9.09e-05	0.00164	CbGeAlD
Zonisamide—CA2—nervous system—acquired immunodeficiency syndrome	8.84e-05	0.00159	CbGeAlD
Zonisamide—CA2—central nervous system—acquired immunodeficiency syndrome	8.51e-05	0.00153	CbGeAlD
Zonisamide—MAOB—brain—acquired immunodeficiency syndrome	8.46e-05	0.00152	CbGeAlD
Zonisamide—MAOB—lymph node—acquired immunodeficiency syndrome	8.17e-05	0.00147	CbGeAlD
Zonisamide—CA4—brain—acquired immunodeficiency syndrome	8.14e-05	0.00147	CbGeAlD
Zonisamide—CA4—lymph node—acquired immunodeficiency syndrome	7.87e-05	0.00142	CbGeAlD
Zonisamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	7.37e-05	0.00133	CbGeAlD
Zonisamide—MAOA—brain—acquired immunodeficiency syndrome	7.21e-05	0.0013	CbGeAlD
Zonisamide—CYP3A4—blood—acquired immunodeficiency syndrome	7.02e-05	0.00127	CbGeAlD
Zonisamide—MAOA—lymph node—acquired immunodeficiency syndrome	6.97e-05	0.00126	CbGeAlD
Zonisamide—CA2—brain—acquired immunodeficiency syndrome	6.75e-05	0.00122	CbGeAlD
Zonisamide—CA2—lymph node—acquired immunodeficiency syndrome	6.53e-05	0.00118	CbGeAlD
Zonisamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	5.7e-05	0.00103	CbGeAlD
Zonisamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	5.49e-05	0.000989	CbGeAlD
Zonisamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	5.12e-05	0.000412	CcSEcCtD
Zonisamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	5.12e-05	0.000412	CcSEcCtD
Zonisamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	5.12e-05	0.000412	CcSEcCtD
Zonisamide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	5.12e-05	0.000412	CcSEcCtD
Zonisamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	5.1e-05	0.000411	CcSEcCtD
Zonisamide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	5.1e-05	0.000411	CcSEcCtD
Zonisamide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	5.1e-05	0.000411	CcSEcCtD
Zonisamide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	5.09e-05	0.000409	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	5.09e-05	0.000409	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	5.07e-05	0.000408	CcSEcCtD
Zonisamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	5.06e-05	0.000407	CcSEcCtD
Zonisamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	5.06e-05	0.000407	CcSEcCtD
Zonisamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	5.06e-05	0.000407	CcSEcCtD
Zonisamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	5.06e-05	0.000407	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	5.05e-05	0.000407	CcSEcCtD
Zonisamide—Cough—Saquinavir—acquired immunodeficiency syndrome	5.05e-05	0.000406	CcSEcCtD
Zonisamide—Constipation—Indinavir—acquired immunodeficiency syndrome	5.02e-05	0.000404	CcSEcCtD
Zonisamide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	5.02e-05	0.000404	CcSEcCtD
Zonisamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	5.02e-05	0.000404	CcSEcCtD
Zonisamide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	5.02e-05	0.000404	CcSEcCtD
Zonisamide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	5.01e-05	0.000403	CcSEcCtD
Zonisamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	5e-05	0.000402	CcSEcCtD
Zonisamide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	4.99e-05	0.000402	CcSEcCtD
Zonisamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	4.99e-05	0.000402	CcSEcCtD
Zonisamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	4.99e-05	0.000401	CcSEcCtD
Zonisamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	4.98e-05	0.000401	CcSEcCtD
Zonisamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	4.98e-05	0.000401	CcSEcCtD
Zonisamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	4.97e-05	0.0004	CcSEcCtD
Zonisamide—Nausea—Didanosine—acquired immunodeficiency syndrome	4.97e-05	0.0004	CcSEcCtD
Zonisamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	4.96e-05	0.000399	CcSEcCtD
Zonisamide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	4.96e-05	0.000399	CcSEcCtD
Zonisamide—Syncope—Lamivudine—acquired immunodeficiency syndrome	4.95e-05	0.000398	CcSEcCtD
Zonisamide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	4.95e-05	0.000398	CcSEcCtD
Zonisamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	4.95e-05	0.000398	CcSEcCtD
Zonisamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	4.94e-05	0.000398	CcSEcCtD
Zonisamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	4.93e-05	0.000397	CcSEcCtD
Zonisamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	4.93e-05	0.000397	CcSEcCtD
Zonisamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	4.93e-05	0.000397	CcSEcCtD
Zonisamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	4.93e-05	0.000397	CcSEcCtD
Zonisamide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	4.91e-05	0.000395	CcSEcCtD
Zonisamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	4.91e-05	0.000395	CcSEcCtD
Zonisamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	4.9e-05	0.000394	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	4.89e-05	0.000394	CcSEcCtD
Zonisamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	4.88e-05	0.000393	CcSEcCtD
Zonisamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	4.87e-05	0.000392	CcSEcCtD
Zonisamide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	4.85e-05	0.000391	CcSEcCtD
Zonisamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	4.84e-05	0.000389	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	4.84e-05	0.000389	CcSEcCtD
Zonisamide—Shock—Ritonavir—acquired immunodeficiency syndrome	4.83e-05	0.000389	CcSEcCtD
Zonisamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	4.82e-05	0.000388	CcSEcCtD
Zonisamide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	4.82e-05	0.000388	CcSEcCtD
Zonisamide—Cough—Lamivudine—acquired immunodeficiency syndrome	4.82e-05	0.000388	CcSEcCtD
Zonisamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	4.82e-05	0.000388	CcSEcCtD
Zonisamide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	4.81e-05	0.000387	CcSEcCtD
Zonisamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	4.81e-05	0.000387	CcSEcCtD
Zonisamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	4.8e-05	0.000387	CcSEcCtD
Zonisamide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	4.8e-05	0.000386	CcSEcCtD
Zonisamide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	4.8e-05	0.000386	CcSEcCtD
Zonisamide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	4.79e-05	0.000385	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	4.79e-05	0.000385	CcSEcCtD
Zonisamide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	4.79e-05	0.000385	CcSEcCtD
Zonisamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	4.78e-05	0.000385	CcSEcCtD
Zonisamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	4.78e-05	0.000385	CcSEcCtD
Zonisamide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	4.77e-05	0.000384	CcSEcCtD
Zonisamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	4.77e-05	0.000384	CcSEcCtD
Zonisamide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	4.76e-05	0.000383	CcSEcCtD
Zonisamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	4.75e-05	0.000382	CcSEcCtD
Zonisamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	4.74e-05	0.000382	CcSEcCtD
Zonisamide—Rash—Nevirapine—acquired immunodeficiency syndrome	4.74e-05	0.000382	CcSEcCtD
Zonisamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	4.74e-05	0.000381	CcSEcCtD
Zonisamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	4.73e-05	0.000381	CcSEcCtD
Zonisamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	4.73e-05	0.000381	CcSEcCtD
Zonisamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	4.72e-05	0.00038	CcSEcCtD
Zonisamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	4.72e-05	0.00038	CcSEcCtD
Zonisamide—Headache—Nevirapine—acquired immunodeficiency syndrome	4.71e-05	0.000379	CcSEcCtD
Zonisamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	4.7e-05	0.000378	CcSEcCtD
Zonisamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	4.7e-05	0.000378	CcSEcCtD
Zonisamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	4.7e-05	0.000378	CcSEcCtD
Zonisamide—Infection—Saquinavir—acquired immunodeficiency syndrome	4.69e-05	0.000378	CcSEcCtD
Zonisamide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	4.69e-05	0.000377	CcSEcCtD
Zonisamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	4.68e-05	0.000376	CcSEcCtD
Zonisamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	4.67e-05	0.000376	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	4.67e-05	0.000376	CcSEcCtD
Zonisamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	4.66e-05	0.000375	CcSEcCtD
Zonisamide—Shock—Saquinavir—acquired immunodeficiency syndrome	4.65e-05	0.000374	CcSEcCtD
Zonisamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	4.65e-05	0.000374	CcSEcCtD
Zonisamide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	4.64e-05	0.000373	CcSEcCtD
Zonisamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	4.64e-05	0.000373	CcSEcCtD
Zonisamide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	4.63e-05	0.000373	CcSEcCtD
Zonisamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	4.63e-05	0.000373	CcSEcCtD
Zonisamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	4.63e-05	0.000372	CcSEcCtD
Zonisamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	4.62e-05	0.000372	CcSEcCtD
Zonisamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	4.61e-05	0.000371	CcSEcCtD
Zonisamide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	4.6e-05	0.00037	CcSEcCtD
Zonisamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	4.59e-05	0.00037	CcSEcCtD
Zonisamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	4.59e-05	0.000369	CcSEcCtD
Zonisamide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	4.59e-05	0.000369	CcSEcCtD
Zonisamide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	4.59e-05	0.000369	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	4.58e-05	0.000369	CcSEcCtD
Zonisamide—Rash—Stavudine—acquired immunodeficiency syndrome	4.58e-05	0.000369	CcSEcCtD
Zonisamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	4.58e-05	0.000368	CcSEcCtD
Zonisamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	4.58e-05	0.000368	CcSEcCtD
Zonisamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	4.57e-05	0.000368	CcSEcCtD
Zonisamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	4.57e-05	0.000367	CcSEcCtD
Zonisamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	4.56e-05	0.000367	CcSEcCtD
Zonisamide—Headache—Stavudine—acquired immunodeficiency syndrome	4.55e-05	0.000366	CcSEcCtD
Zonisamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	4.55e-05	0.000366	CcSEcCtD
Zonisamide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	4.54e-05	0.000366	CcSEcCtD
Zonisamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	4.54e-05	0.000365	CcSEcCtD
Zonisamide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	4.54e-05	0.000365	CcSEcCtD
Zonisamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	4.53e-05	0.000364	CcSEcCtD
Zonisamide—Rash—Abacavir—acquired immunodeficiency syndrome	4.51e-05	0.000363	CcSEcCtD
Zonisamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	4.51e-05	0.000363	CcSEcCtD
Zonisamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	4.51e-05	0.000363	CcSEcCtD
Zonisamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	4.5e-05	0.000362	CcSEcCtD
Zonisamide—Headache—Abacavir—acquired immunodeficiency syndrome	4.48e-05	0.000361	CcSEcCtD
Zonisamide—Infection—Lamivudine—acquired immunodeficiency syndrome	4.48e-05	0.00036	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	4.47e-05	0.00036	CcSEcCtD
Zonisamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	4.47e-05	0.00036	CcSEcCtD
Zonisamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	4.47e-05	0.000359	CcSEcCtD
Zonisamide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	4.44e-05	0.000357	CcSEcCtD
Zonisamide—Shock—Lamivudine—acquired immunodeficiency syndrome	4.43e-05	0.000357	CcSEcCtD
Zonisamide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.000356	CcSEcCtD
Zonisamide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	4.41e-05	0.000355	CcSEcCtD
Zonisamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.000355	CcSEcCtD
Zonisamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	4.41e-05	0.000355	CcSEcCtD
Zonisamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	4.41e-05	0.000355	CcSEcCtD
Zonisamide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	4.39e-05	0.000353	CcSEcCtD
Zonisamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	4.39e-05	0.000353	CcSEcCtD
Zonisamide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	4.38e-05	0.000352	CcSEcCtD
Zonisamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	4.38e-05	0.000352	CcSEcCtD
Zonisamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	4.37e-05	0.000352	CcSEcCtD
Zonisamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	4.36e-05	0.000351	CcSEcCtD
Zonisamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	4.36e-05	0.000351	CcSEcCtD
Zonisamide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	4.34e-05	0.000349	CcSEcCtD
Zonisamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	4.33e-05	0.000348	CcSEcCtD
Zonisamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	4.33e-05	0.000348	CcSEcCtD
Zonisamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	4.32e-05	0.000348	CcSEcCtD
Zonisamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	4.32e-05	0.000348	CcSEcCtD
Zonisamide—Nausea—Stavudine—acquired immunodeficiency syndrome	4.31e-05	0.000347	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	4.3e-05	0.000346	CcSEcCtD
Zonisamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	4.3e-05	0.000346	CcSEcCtD
Zonisamide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	4.27e-05	0.000344	CcSEcCtD
Zonisamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000343	CcSEcCtD
Zonisamide—Nausea—Abacavir—acquired immunodeficiency syndrome	4.25e-05	0.000342	CcSEcCtD
Zonisamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	4.24e-05	0.000341	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	4.24e-05	0.000341	CcSEcCtD
Zonisamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	4.23e-05	0.000341	CcSEcCtD
Zonisamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	4.22e-05	0.000339	CcSEcCtD
Zonisamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	4.21e-05	0.000339	CcSEcCtD
Zonisamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	4.21e-05	0.000339	CcSEcCtD
Zonisamide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	4.21e-05	0.000339	CcSEcCtD
Zonisamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	4.2e-05	0.000338	CcSEcCtD
Zonisamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	4.2e-05	0.000338	CcSEcCtD
Zonisamide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	4.2e-05	0.000338	CcSEcCtD
Zonisamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	4.2e-05	0.000338	CcSEcCtD
Zonisamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	4.18e-05	0.000336	CcSEcCtD
Zonisamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	4.16e-05	0.000335	CcSEcCtD
Zonisamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	4.15e-05	0.000334	CcSEcCtD
Zonisamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.00033	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.11e-05	0.00033	CcSEcCtD
Zonisamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	4.09e-05	0.000329	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	4.08e-05	0.000328	CcSEcCtD
Zonisamide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	4.08e-05	0.000328	CcSEcCtD
Zonisamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	4.07e-05	0.000328	CcSEcCtD
Zonisamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.05e-05	0.000326	CcSEcCtD
Zonisamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	4.05e-05	0.000325	CcSEcCtD
Zonisamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	4.04e-05	0.000325	CcSEcCtD
Zonisamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	4.02e-05	0.000323	CcSEcCtD
Zonisamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.02e-05	0.000323	CcSEcCtD
Zonisamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.01e-05	0.000323	CcSEcCtD
Zonisamide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.01e-05	0.000323	CcSEcCtD
Zonisamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	4.01e-05	0.000322	CcSEcCtD
Zonisamide—Rash—Zidovudine—acquired immunodeficiency syndrome	3.98e-05	0.00032	CcSEcCtD
Zonisamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	3.98e-05	0.00032	CcSEcCtD
Zonisamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	3.98e-05	0.00032	CcSEcCtD
Zonisamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	3.97e-05	0.000319	CcSEcCtD
Zonisamide—Headache—Zidovudine—acquired immunodeficiency syndrome	3.96e-05	0.000318	CcSEcCtD
Zonisamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.93e-05	0.000316	CcSEcCtD
Zonisamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.000315	CcSEcCtD
Zonisamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	3.91e-05	0.000315	CcSEcCtD
Zonisamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	3.9e-05	0.000314	CcSEcCtD
Zonisamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000313	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3.89e-05	0.000313	CcSEcCtD
Zonisamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	3.89e-05	0.000313	CcSEcCtD
Zonisamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	3.88e-05	0.000312	CcSEcCtD
Zonisamide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000312	CcSEcCtD
Zonisamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000312	CcSEcCtD
Zonisamide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	3.86e-05	0.000311	CcSEcCtD
Zonisamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	3.85e-05	0.00031	CcSEcCtD
Zonisamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	3.81e-05	0.000306	CcSEcCtD
Zonisamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	3.8e-05	0.000305	CcSEcCtD
Zonisamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	3.76e-05	0.000302	CcSEcCtD
Zonisamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	3.75e-05	0.000302	CcSEcCtD
Zonisamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	3.75e-05	0.000302	CcSEcCtD
Zonisamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000301	CcSEcCtD
Zonisamide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000301	CcSEcCtD
Zonisamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	3.73e-05	0.0003	CcSEcCtD
Zonisamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000299	CcSEcCtD
Zonisamide—Rash—Indinavir—acquired immunodeficiency syndrome	3.7e-05	0.000298	CcSEcCtD
Zonisamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	3.7e-05	0.000298	CcSEcCtD
Zonisamide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	3.69e-05	0.000297	CcSEcCtD
Zonisamide—Headache—Indinavir—acquired immunodeficiency syndrome	3.68e-05	0.000296	CcSEcCtD
Zonisamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	3.67e-05	0.000295	CcSEcCtD
Zonisamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	3.63e-05	0.000292	CcSEcCtD
Zonisamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	3.62e-05	0.000291	CcSEcCtD
Zonisamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	3.58e-05	0.000288	CcSEcCtD
Zonisamide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000287	CcSEcCtD
Zonisamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000287	CcSEcCtD
Zonisamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	3.53e-05	0.000284	CcSEcCtD
Zonisamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	3.52e-05	0.000283	CcSEcCtD
Zonisamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	3.51e-05	0.000282	CcSEcCtD
Zonisamide—Rash—Efavirenz—acquired immunodeficiency syndrome	3.5e-05	0.000281	CcSEcCtD
Zonisamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	3.49e-05	0.000281	CcSEcCtD
Zonisamide—Nausea—Indinavir—acquired immunodeficiency syndrome	3.49e-05	0.000281	CcSEcCtD
Zonisamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	3.48e-05	0.00028	CcSEcCtD
Zonisamide—Headache—Efavirenz—acquired immunodeficiency syndrome	3.48e-05	0.00028	CcSEcCtD
Zonisamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	3.47e-05	0.000279	CcSEcCtD
Zonisamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	3.39e-05	0.000273	CcSEcCtD
Zonisamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	3.38e-05	0.000272	CcSEcCtD
Zonisamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	3.36e-05	0.00027	CcSEcCtD
Zonisamide—Rash—Delavirdine—acquired immunodeficiency syndrome	3.35e-05	0.000269	CcSEcCtD
Zonisamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	3.34e-05	0.000269	CcSEcCtD
Zonisamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	3.34e-05	0.000269	CcSEcCtD
Zonisamide—Headache—Delavirdine—acquired immunodeficiency syndrome	3.33e-05	0.000268	CcSEcCtD
Zonisamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	3.32e-05	0.000267	CcSEcCtD
Zonisamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.3e-05	0.000265	CcSEcCtD
Zonisamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	3.25e-05	0.000261	CcSEcCtD
Zonisamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.23e-05	0.00026	CcSEcCtD
Zonisamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.23e-05	0.00026	CcSEcCtD
Zonisamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	3.19e-05	0.000257	CcSEcCtD
Zonisamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.15e-05	0.000254	CcSEcCtD
Zonisamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.12e-05	0.000251	CcSEcCtD
Zonisamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.12e-05	0.000251	CcSEcCtD
Zonisamide—Rash—Ritonavir—acquired immunodeficiency syndrome	3.1e-05	0.000249	CcSEcCtD
Zonisamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.09e-05	0.000249	CcSEcCtD
Zonisamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.08e-05	0.000248	CcSEcCtD
Zonisamide—Headache—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.000247	CcSEcCtD
Zonisamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3e-05	0.000242	CcSEcCtD
Zonisamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.98e-05	0.00024	CcSEcCtD
Zonisamide—Rash—Saquinavir—acquired immunodeficiency syndrome	2.98e-05	0.00024	CcSEcCtD
Zonisamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.98e-05	0.000239	CcSEcCtD
Zonisamide—Headache—Saquinavir—acquired immunodeficiency syndrome	2.96e-05	0.000238	CcSEcCtD
Zonisamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.92e-05	0.000235	CcSEcCtD
Zonisamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000231	CcSEcCtD
Zonisamide—Rash—Lamivudine—acquired immunodeficiency syndrome	2.84e-05	0.000229	CcSEcCtD
Zonisamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.84e-05	0.000228	CcSEcCtD
Zonisamide—Headache—Lamivudine—acquired immunodeficiency syndrome	2.82e-05	0.000227	CcSEcCtD
Zonisamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.81e-05	0.000226	CcSEcCtD
Zonisamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.68e-05	0.000215	CcSEcCtD
